New protein found in immune cells
Susana Minguet
B lymphocytes, also known as B cells, are the only cells to produce antibodies, which the immune system needs to fight off foreign intruders like pathogens in order to protect the human body. On their surface, B cells carry B cell receptors. These activate the B cells when an antigen - a substance on the surface of a pathogenic germ - binds to them. The team of scientists from the University of Freiburg has discovered that Kidins220/ARMS interacts with the B cell receptor and affects signalling pathways from the receptor to the interior of the cell. Without Kidins220/ARMS, the receptor's ability to send signals is limited. As a result, the B cells manufacture less antibodies and the immune system is weakened.
Kidins220/ARMS is also vital for the formation of B cells. If a mouse cannot produce this protein, the B lymphocytes develop in a way that makes them less functional than the B cells of a healthy immune system. The reason for this is that B cells depend on the signals from the B cell receptor and pre-B cell receptor, which is the early version of a B cell receptor, at various stages of their development. Deficiency in Kidins220/ARMS therefore obstructs the development of B cells.
Original publication
Gina J. Fiala, Iga Janowska, Fabiola Prutek, Elias Hobeika, Annyesha Satapathy, Adrian Sprenger, Thomas Plum, Maximilian Seidl, Jörn Dengjel, Michael Reth, Fabrizia Cesca, Tilman Brummer, Susana Minguet, and Wolfgang W.A. Schamel; "Kidins220/ARMS binds to the B cell antigen receptor and regulates B cell development and activation"; J Exp Med; 2015
Most read news
Original publication
Gina J. Fiala, Iga Janowska, Fabiola Prutek, Elias Hobeika, Annyesha Satapathy, Adrian Sprenger, Thomas Plum, Maximilian Seidl, Jörn Dengjel, Michael Reth, Fabrizia Cesca, Tilman Brummer, Susana Minguet, and Wolfgang W.A. Schamel; "Kidins220/ARMS binds to the B cell antigen receptor and regulates B cell development and activation"; J Exp Med; 2015
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.